| Products | Targeted Therapies | Type |
|---|
| Lapatinib | HER2-positive metastatic breast cancer. | Kinase Inhibitors |
| Nilotinib | Chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). | Kinase Inhibitors |
| Baricitinib | Rheumatoid arthritis and alopecia areata. | Kinase Inhibitors |
| Tucatinib | HER2-positive metastatic breast cancer. | Kinase Inhibitors |
| Ponatinib | Chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). | Kinase Inhibitors |
| Alectinib | Anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC). | Kinase Inhibitors |
| Crizotinib | ALK-positive NSCLC and ROS1 fusion-positive NSCLC. | Kinase Inhibitors |
| Flumatinib | Chronic myelogenous leukemia (CML). | Kinase Inhibitors |
| Ruxolitinib | Myelofibrosis and polycythemia vera. | Kinase Inhibitors |
| Lenvatinib | Thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma. | Kinase Inhibitors |
| Dasatinib | CML and Ph+ ALL. | Kinase Inhibitors |
| Apatinib | Gastrointestinal stromal tumors (GIST). | Kinase Inhibitors |
| Dacomitinib | Non-small cell lung cancer (NSCLC). | Kinase Inhibitors |
| Gefitinib | NSCLC with EGFR mutations. | Kinase Inhibitors |
| Imatinib | CML, gastrointestinal stromal tumors (GIST), and other cancers. | Kinase Inhibitors |
| N-desmethylimatinib | A metabolite of imatinib with similar activity. | Kinase Inhibitors |
| Ibrutinib | Chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. | Kinase Inhibitors |
| Osimertinib | NSCLC with EGFR mutations, including T790M mutation. | Kinase Inhibitors |
| Afatinib | NSCLC with EGFR mutations. | Kinase Inhibitors |
| Erlotinib | NSCLC with EGFR mutations. | Kinase Inhibitors |
| Doxorubicin | A broad-spectrum anticancer drug used to treat various cancers. | Traditional Chemotherapy Agents |
| Methotrexate | An antifolate drug used to treat various cancers, autoimmune diseases, and ectopic pregnancies. | Traditional Chemotherapy Agents |
| Paclitaxel | A taxane chemotherapy drug used to treat various cancers, including breast, lung, and ovarian cancer. | Traditional Chemotherapy Agents |
| Docetaxel | A variety of cancers - including breast, head and neck, gastric, prostate, and non-small cell lung cancer. | Traditional Chemotherapy Agents |
| 5-Fluorouracil | A pyrimidine analog chemotherapy drug used to treat various cancers, including colorectal, breast, and gastrointestinal cancers. | Traditional Chemotherapy Agents |
Stable isotope drug release method. [2]